FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

ALKYLAMINE

2,708.95
+166.85 (6.56%)
Updated 03:29 11/08 IST

ALKYLAMINE Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for ALKYLAMINE
Disclaimer
0% Bullish
0% Bearish

ALKYLAMINE Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See ALKYLAMINE Share Price Targets >>

ALKYLAMINE Ratings

Long term ALKYLAMINE rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live ALKYLAMINE message board: Is ALKYLAMINE buy or sell? Should I buy ALKYLAMINE shares? Why are ALKYLAMINE shares falling? Should I invest in ALKYLAMINE stock?

  1. Home
  2. ALKYLAMINE Forum

ALKYLAMINE Share Price Discussion

N
Reputation: 4,641 • Aug 5 4:03 AM
Over 70 stocks in BSE500 hit 52-week high in July; time to chase momentum?
Experts say going ahead auto, pharma and chemicals sector look attractive. Analysts name 20 stocks that have a potential to outperform in August. These include Wockhardt, PI Industries and Rallis India
Moneycontrol
Like
Reply
N
Reputation: 4,641 • Jul 9 6:13 AM
Infosys, Bharti Airtel, ICICI Bank among 26 stocks on analysts' radar post Q4 FY20
The market's valuations have turned higher than long-period average and investors should be cautious and selective in picking stocks, say experts .
Moneycontrol
Like
Reply
H
Reputation: -1,057 • Jul 2 3:07 AM

Type
Buy
Instrument
ALKYLAMINE
Entry Price
₹2,169
Price@Trade
₹2,175
Target Price
₹3,000
Stop Price
₹2,100
Valid Till
Jul 2, 2021 3:20 AM
Margin
₹216,900 approx for 100 Qty
Status
Exited
Exit Price
₹2,249.85
Net P&L
+₹8,085 (+3.73%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jul 2 3:09 AM

Update
Trade Entered
Entry Price
₹2,169
Hemant Garg @hemantgarg1989
Jul 6 2:49 AM

Update
Exited
Exit Price
₹2,249.85
Net P&L
+₹8,085 (+3.73%)
N
Reputation: 4,641 • Jun 26 11:03 AM
Buy Alkyl Amines; target of Rs 2500: HDFC Securities
HDFC Securities is bullish on Alkyl Amines has recommended buy rating on the stock with a target price of Rs 2500 in its research report dated June 26, 2020.
Moneycontrol
Like
Reply
N
Reputation: 4,641 • Jun 24 3:43 AM
Alkyl Amines Consolidated March 2020 Net Sales at Rs 234.77 crore, down 1.13% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,641 • Jun 19 7:13 AM
Sunny days ahead for Indian chemicals industry; experts bullish on these 10 stocks
The Indian chemicals sector has built up world-class capabilities over the past few years and been moving up the value chain at a rapid pace.
Moneycontrol
1
Reply
N
Reputation: 4,641 • Jun 16 8:21 AM
HDFC Securities lists 5 stocks that will benefit from the Aatma Nirbhar Bharat push
‘Specialty chemicals, pharma, auto ancillaries will benefit a lot
The Economic Times
Like
Reply
S
Reputation: 248 • Jun 12 6:55 AM

Type
Buy
Instrument
ALKYLAMINE
Entry Price
₹2,087
Price@Trade
₹2,095
Target Price
₹2,300
Stop Price
₹2,055
Valid Till
Jul 10, 2020 3:20 AM
Margin
₹208,700 approx for 100 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Shardia @shardia
Jun 12 8:33 AM

Update
Exited before entry
Price @ Update
₹2,096.2
N
Reputation: 4,641 • Jun 3 8:03 AM
Midcaps may take time to catch-up; 12 names to bet on amid uncertainty
While the large-cap stocks have been rising, experts believe as sectors, mid-caps and small-caps will take a longer time to pick up as bigger companies could be in a better position to grab higher market share in their respective sectors after the lockdown ends.
Moneycontrol
Like
Reply
N
Reputation: 4,641 • Jun 1 7:08 AM
Chemicals look attractive in times of uncertainty; ICICI Direct picks 5 stocks that can rise up to 20%
The size of the Indian chemical industry is estimated to be around $165 billion, representing a market share of 3.4 percent in the global chemical market.
Moneycontrol
Like
Reply

Type
Buy
Instrument
ALKYLAMINE
Entry Price
₹2,016  ₹2,033
Price@Trade
₹2,006
Target Price
₹2,300
Stop Price
₹1,850
Valid Till
Jun 26, 2020 3:20 AM
Margin
₹101,650 approx for 50 Qty
Status
Exited
Exit Price
₹2,082
Net P&L
+₹2,450 (+2.41%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 28 2:46 AM

Update
Trade Entered
Entry Price
₹2,033

Update
Exited
Exit Price
₹2,082
Net P&L
+₹2,450 (+2.41%)

ALKYLAMINE - chart - 829609
For more check Chart
ALKYL AMINES BOUGHT TODAY AT 1889
Like
Reply
N
Reputation: 4,641 • May 5 6:58 AM
Alkyl Amines Q4 PAT may dip 14.2% YoY to Rs. 26 cr: HDFC Securities
Net Sales are expected to decrease by 15.4 percent Y-o-Y (down 8.5 percent Q-o-Q) to Rs. 217 crore, according to HDFC Securities.
Moneycontrol
Like
Reply
N
Reputation: 4,641 • Feb 22 5:13 AM
Portfolio play: Gold likely to touch $1,700/ounce levels in 2020
Gold is likely to touch levels of $1700/ounce in the year 2020 and it is a buy even at the current levels if investors are considering it from a long-term perspective.
Moneycontrol
Like
Reply
N
Reputation: 4,641 • Feb 6 8:33 AM
Advanced Enzyme, Alkyl Amines gain 4-7% on better Q3 show
Alkyl Amines has registered 172 percent jump in its Q3 consolidated net profit at Rs 60.4 crore versus Rs 22.2 crore, YoY.
Moneycontrol
Like
Reply

**BUY ALKYLAMINE AT CMP 1400 TG 1410-1420-1430**
Like
Reply

**BUY ALKYLAMINE AT CMP 1400 TG 1410-1420-1430**
Like
Reply
Like
Reply
R
Reputation: 1,213 • Nov 7, 2019 4:12 AM
Ravi Prasad(RSP)🇮🇳 on Twitter
“RSP's Technical View TIA 20-20 IDEAS SUMMIT 2019 Stocks @TIA_Investors @jaganmsna Pick1 : AlkylAmines by @varinder_bansal +VeFactor: Trading in Upwardchannel, trading abv 200mvngavg #Channel Buy at sup”
Twitter
2
Reply

Alkyl Amines Chemicals reported good numbers. Revenue from operations grew 7.3% y/y to Rs 234.97 crore. Margin expanded 200bps y/y to 24.6%, the share of profit from associate company has rose 60% to Rs 1.63 crore. PAT at Rs 55 crore is up 107% y/y.
4
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • ALKYLAMINE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,710.95
    Enterprise Value1,820.78
    Price to Earnings19.3
    Price to Book Value4.69
    Return on Capital Employed0.22
    Return on Equity0.22
    Face Value5
    Dividend Yield0.01
  • ALKYLAMINE - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    2-Feb-19HDFC SecuritiesBuy1,306
    3-Aug-18KRChokseyBuy766
    23-May-18HDFC SecuritiesBuy900
    11-Dec-17KRChokseyBuy762
    ALKYLAMINE Brokerage Price Target
  • ALKYLAMINE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 11257027192560.12691.9
    Aug 102496.525532444.22542.1
    Aug 72430245023852444.2
    Aug 625202537.6524072416.5
    Aug 52409.9250024002475.7
  • ALKYLAMINE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,346.13
    30 Day Moving Average₹2,322.68
    50 Day Moving Average₹2,227.83
    100 Day Moving Average₹1,895.51
    200 Day Moving Average₹1,545.07
  • ALKYLAMINE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue616500.640.23
    Operating Profit11791.690.28
    Profit Before Tax9572.790.31
    Net Income6449.610.29
  • ALKYLAMINE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3652960.23
    Total Liabilities3843420.12
    Total Assets7496390.17
  • ALKYLAMINE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity10162.280.62
    Cash from Investing Activity-132-75.510.75
    Cash from Financing Activity3212.521.56
    Net Cash Flow1-0.71-2.41
  • ALKYLAMINE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.10.1
    Return on Equity0.220.2
    Return on Capital Employed0.220.21
  • ALKYLAMINE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.29
    3 Year CAGR Growth in Operating Profit0.35
    3 Year CAGR Growth in EBIDTA0.33
    3 Year CAGR Growth in Net Income0.41
    3 Yr CAGR Growth - Diluted EPS0.41
  • ALKYLAMINE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.68
    5 Year CAGR Growth in Operating Profit1.03
    5 Year CAGR Growth in EBIDTA1
    5 Year CAGR Growth in Net Income1.67
    3 Yr CAGR Growth - Diluted EPS0.34
  • ALKYLAMINE - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 26 11:03 AM
    Buy Alkyl Amines; target of Rs 2500: HDFC Securities
    Moneycontrol
    NewsBot
    Jun 24 3:43 AM
    Alkyl Amines Consolidated March 2020 Net Sales at Rs 234.77 crore, down 1.13% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 16 8:21 AM
    HDFC Securities lists 5 stocks that will benefit from the Aatma Nirbhar Bharat push
    The Economic Times
    NewsBot
    May 5 6:58 AM
    Alkyl Amines Q4 PAT may dip 14.2% YoY to Rs. 26 cr: HDFC Securities
    Moneycontrol
    NewsBot
    Feb 22 5:13 AM
    Portfolio play: Gold likely to touch $1,700/ounce levels in 2020
    Moneycontrol
    NewsBot
    Feb 6 8:33 AM
    Advanced Enzyme, Alkyl Amines gain 4-7% on better Q3 show
    Moneycontrol
    NewsBot
    Sep 30, 2019 7:53 AM
    Ranitidine controversy: Which Indian pharma companies stand to lose?
    Moneycontrol
    NewsBot
    Aug 6, 2019 9:43 AM
    Alkyl Amines Standalone June 2019 Net Sales at Rs 266.23 crore, up 49.45% Y-o-Y
    moneycontrol.com
    NewsBot
    Jul 17, 2019 7:58 AM
    NewsBot
    May 21, 2019 8:28 AM
  • ALKYLAMINE - Related Communities

    keyboard_arrow_down
    UPL Ltd. NSE: UPL | BSE: 512070 | ISI...
    Pidilite Industries Ltd. NSE: PIDILIT...
    Tata Chemicals Ltd. NSE: TATACHEM | B...
    Godrej Industries Ltd. NSE: GODREJIND...
    Deepak Nitrite Ltd. NSE: DEEPAKNTR | ...
    Aarti Industries Ltd. NSE: AARTIIND |...
    Rallis India Ltd. NSE: RALLIS | BSE: ...
    PI Industries Ltd. NSE: PIIND | BSE: ...
    Himadri Speciality Chemical Ltd. NSE:...
    Meghmani Organics Ltd. NSE: MEGH | BS...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020